Hiroko Nishida1, Mutsumi Hayashi1, Chikao Morimoto2, Michiie Sakamoto1, Taketo Yamada1,3 (1.Pathol., Keio Univ., Tokyo, Japan, 2.Grad. Sch. Med., Juntendo Univ, Tokyo, Japan, 3.Pathol., Saitama Med. Univ., Facul. Saitama, Japan)
Session information
Oral Session
Oral Session 2-9A Multiple Myeloma: Basic (1)
Sat. Oct 12, 2019 9:00 AM - 10:00 AM No.9 (Tokyo International Forum, 4F G402)
Chair: Naoki Hosen (Dept of Cancer Stem Cell Biology, Osaka University Graduate School of Medicine)
Yusuke Inoue1,2, Takeshi Harada3, Asuka Oda1, Masahiro Oura1,3, Kimiko Sogabe1, Kengo Udaka3, Shiro Fujii3, Shingen Nakamura1, Hirokazu Miki4, Kumiko Kagawa3, Masahiro Abe1 (1.Department of Hematology, Endocrinology and Metabolism, Tokushima University, Japan, 2.Department of Laboratory Medicine, Tokushima University Hospital, Japan, 3.Department of Hematology, Tokushima University Hospital, Japan, 4.Department of Transfusion Medicine and Cell Therapy, Tokushima University, Japan)
Saeko Ota1, Yuji Shimura1, Reiko Isa1, Junko Yamaguchi1, Yuto Fujibayashi1, Daichi Nishiyama1, Tomoko Shimomura1, Yoshimi Mizuno1, Yayoi Kimoto1, Taku Tsukamoto1, Yoshiaki Chinen1, Tsutomu Kobayashi1, Shigeo Horiike1, Masafumi Taniwaki2, Junya Kuroda1 (1.Div., Hematol., Oncol., Kyoto Prefectural University of Medicine, 2.Molecular Diagnostics Therapeutics, Kyoto Prefectural University of Medicine)
[OS2-9A-4] Functional and clinical assessment of mitotic checkpoint protein BUB1 in multiple myeloma
Yuto Fujibayashi1, Natsumi Inada1, Saeko Ota1, Reiko Isa1, Junko Yamaguchi1, Daichi Nishiyama1, Yayoi Kimoto1, Yoshiaki Chinen1, Yuji Shimura1, Tsutomu Kobayashi1, Masafumi Taniwaki2, Junya Kuroda1 (1.Hematology and Oncology, Kyoto Pref. Univ. Med., Japan, 2.Molecular Diagnostics and Therapeutics, Kyoto Pref. Univ. Med., Japan)
[OS2-9A-5] A novel PDK1 inhibitor, JX06, dephosphorylates PDH and induces apoptosis in myeloma cells
Takayuki Sasano1, Yawara Kawano2, Saki Kushima1, Masao Matsuoka2, Hiroyuki Hata1 (1.Faculty of Medical Sciences, Kumamoto University, 2.Departments of Hematology, Rheumatology, and Infectious Disease, Kumamoto University Hospital)
Sho Ikeda, Fumito Abe, Akihiro Kitadate, Naoto Takahashi, Hiroyuki Tagawa (Department of Hematology, Nephrology, and Rheumatology, Akita Univ., Akita, Japan)